These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21823589)

  • 1. Current status and research strategies in tuberculosis drug development.
    Dover LG; Coxon GD
    J Med Chem; 2011 Sep; 54(18):6157-65. PubMed ID: 21823589
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
    Yew WW; Koh WJ
    Korean J Intern Med; 2016 Jan; 31(1):15-29. PubMed ID: 26767853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative genomics and anti-tuberculosis drug target discovery].
    Shi WJ; Zhang XL; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):54-7. PubMed ID: 18366909
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of new antituberculosis drugs in mouse models.
    Davies GR; Pym AS; Mitchison DA; Nuermberger EL; Grosset JH
    Antimicrob Agents Chemother; 2007 Jan; 51(1):403; author reply 403-4. PubMed ID: 17182861
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging drugs for the treatment of tuberculosis.
    Yew WW; Cynamon M; Zhang Y
    Expert Opin Emerg Drugs; 2011 Mar; 16(1):1-21. PubMed ID: 20868293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 7. Infectious disease. More than just bugs in spit.
    Barry C
    Science; 2015 May; 348(6235):633-4. PubMed ID: 25953992
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating pyrazinamide mono-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Pérez-Arellano CP; García-Toledo D
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1244-5. PubMed ID: 23928174
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for chemotherapy of tuberculosis in Taiwan.
    ; ; ; ;
    J Microbiol Immunol Infect; 2004 Dec; 37(6):382-4. PubMed ID: 15599473
    [No Abstract]   [Full Text] [Related]  

  • 10. A new weapon against TB?
    Ashraf H
    Drug Discov Today; 2005 Feb; 10(4):230-1. PubMed ID: 15708737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Occurence of primary resistance in hospital patients with respiratory tuberculosis].
    Serdarević H; Bogdanović M; Travnik H; Simeonov L
    Tuberkuloza; 1966; 18(1-3):220-7. PubMed ID: 16296090
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].
    Corlan E
    Pneumoftiziologia; 1992; 41(4):231-42. PubMed ID: 1339503
    [No Abstract]   [Full Text] [Related]  

  • 13. Why is long-term therapy required to cure tuberculosis?
    Connolly LE; Edelstein PH; Ramakrishnan L
    PLoS Med; 2007 Mar; 4(3):e120. PubMed ID: 17388672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regimens of chemotherapy for pulmonary tuberculosis--second report. A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation.
    Tubercle; 1974 Sep; 55(3):169-92. PubMed ID: 4220080
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug resistance in tuberculosis control.
    Shimao T
    Tubercle; 1987 Jun; 68(2 Suppl):5-18. PubMed ID: 3120383
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular detection of resistance to antituberculous therapy.
    Marttila HJ; Soini H
    Clin Lab Med; 2003 Dec; 23(4):823-41, v-vi. PubMed ID: 14711094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymeric complexes of isonicotinic acid hydrazide with antituberculosis effects.
    Slivkin AI; Lapenko VL; Bychuk AI; Suslina SN; Slivkin DA; Kornienko SV; Belenova AS
    Bull Exp Biol Med; 2013 Oct; 155(6):764-6. PubMed ID: 24288761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C; Velluti G; Mantovani P
    Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.